SKC Co. Ltd. completed the acquisition of an additional 4.39% stake in Bioland Co., Ltd. from Chan Bok Jeong.
July 13, 2015
Share
SKC Co. Ltd. (KOSE:A011790) agreed to acquire an additional 4.39% stake in Bioland Co., Ltd. (KOSDAQ:A052260) from Chan Bok Jeong for KRW 16.3 billion on June 26, 2015. SKC Co. Ltd. will acquire 0.66 million shares and increase its stake to 4.19 million shares. The transaction is regarding the exercise of put option between SKC Co. Ltd. and Chan Bok Jeong. Board of Directors of SKC Co. Ltd. made a resolution in favor of the transaction on July 5, 2015.
SKC Co. Ltd. (KOSE:A011790) completed the acquisition of an additional 4.39% stake in Bioland Co., Ltd. (KOSDAQ:A052260) from Chan Bok Jeong on July 14, 2015.
Hyundai Bioland Co Ltd, formerly SK Bio Land Co Ltd, is a Korea-based company mainly engaged in the development and manufacture of raw materials for cosmetics. The Company operates its business through four segments. The Cosmetic Raw Material segment produces products such as portulaca extracts, ulmus extracts, crinum extracts, hyaluronic acids and arbutins. The Pharmaceutical Ingredient segment manufactures and sells products such as phellodendron extracts, ampelopsis extracts and gardenia extracts and others. The Ingredients for Health Functional Food segment produces and distributes red ginseng extract powders, seaweed powders, glucosamine powders, black garlic extract powders, dandelion extract powders, green tea extracts and others. The Medical Device segment involves in the provision of medical equipment such as tissue engineering products, comprised of biological wound dressings and collagen, as well as diagnostic kits, comprised of rapid kits, serological kits and mask packs.